John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 195,299 shares at $300.80 ($59.9M) on 2025-12-16, disclosed to the SEC on 2025-12-17.
Scheduled sale ($59.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $301.58 | 1,791 | $540K | 0.9% |
| 2 | $301.58 | 1,791 | $540K | 0.9% |
| 3 | $302.29 | 6,389 | $1.9M | 3.2% |
| 4 | $302.29 | 6,389 | $1.9M | 3.2% |
| 5 | $303.60 | 1,896 | $576K | 1.0% |
| 6 | $303.60 | 1,896 |
| $576K |
| 1.0% |
| 7 | $304.37 | 5,829 | $1.8M | 3.0% |
| 8 | $304.37 | 5,829 | $1.8M | 3.0% |
| 9 | $305.55 | 3,940 | $1.2M | 2.0% |
| 10 | $306.39 | 4,949 | $1.5M | 2.5% |
| 11 | $306.39 | 4,949 | $1.5M | 2.5% |
| 12 | $307.38 | 5,118 | $1.6M | 2.6% |
| 13 | $307.38 | 5,118 | $1.6M | 2.6% |
| 14 | $308.41 | 14,163 | $4.4M | 7.3% |
| 15 | $308.41 | 14,163 | $4.4M | 7.3% |
| 16 | $309.37 | 10,650 | $3.3M | 5.5% |
| 17 | $309.37 | 10,650 | $3.3M | 5.5% |
| 18 | $310.48 | 16,318 | $5.1M | 8.5% |
| 19 | $310.48 | 16,318 | $5.1M | 8.5% |
| 20 | $311.33 | 2,344 | $730K | 1.2% |
| 21 | $311.33 | 2,344 | $730K | 1.2% |
| 22 | $311.93 | 121 | $38K | 0.1% |
| 23 | $313.52 | 929 | $291K | 0.5% |
| 24 | $313.52 | 929 | $291K | 0.5% |
| 25 | $314.92 | 1,194 | $376K | 0.6% |
| 26 | $314.92 | 1,194 | $376K | 0.6% |
| 27 | $300.80 | 1,877 | $565K | 0.9% |
| 28 | $300.80 | 1,877 | $565K | 0.9% |
| 29 | $300.98 | 600 | $181K | 0.3% |
| 30 | $301.79 | 2,567 | $775K | 1.3% |
| 31 | $301.79 | 2,567 | $775K | 1.3% |
| 32 | $302.31 | 1,512 | $457K | 0.8% |
| 33 | $302.31 | 1,512 | $457K | 0.8% |
| 34 | $302.74 | 7,470 | $2.3M | 3.8% |
| 35 | $302.74 | 7,470 | $2.3M | 3.8% |
| 36 | $303.13 | 1,633 | $495K | 0.8% |
| 37 | $303.13 | 1,633 | $495K | 0.8% |
| 38 | $303.72 | 5,442 | $1.7M | 2.8% |
| 39 | $303.72 | 5,442 | $1.7M | 2.8% |
| 40 | $304.13 | 1,255 | $382K | 0.6% |
| 41 | $304.13 | 1,255 | $382K | 0.6% |
| 42 | $304.36 | 1,973 | $601K | 1.0% |
| 43 | $304.36 | 1,973 | $601K | 1.0% |
| 44 | $305.24 | 40 | $12K | 0.0% |
| Total | $306.63 avg | 195,299 | $59.9M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |